News
-
-
-
-
PRESS RELEASE
Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report
Xlife Sciences AG reports strong portfolio growth and strategic advances in the 2023 Valuation Report by independent consulting firm CYLAD Experts. Portfolio valued at CHF 611.7-747.8 million -
-
-
-
-
-
PRESS RELEASE
Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland
Xlife Sciences AG announces collaboration agreement between its portfolio company FUSE-AI GmbH and T-Systems Switzerland to distribute AI-powered software for radiology clinics. The partnership aims to increase efficiency and reduce misdiagnoses